$CALM

Freshpet (FRPT) reported Q2 revenue of $305.6M, up 15.5% YoY, beating estimates. Cal-Maine (CALM) saw revenue drop 41.5% YoY to $539.6M, missing expectations. Pilgrim's Pride (PPC) reported $4.63B revenue, down 2.8% YoY, also missing estimates. United Natural Foods (UNFI) reported flat revenue at $7.64B, slightly missing expectations. All stocks except UNFI are down since reporting.

Cal-Maine Foods reports signs of U.S. egg supply-demand rebalancing, but no timeline for the end of the glut. Q1 sales fell 59.5% YoY to $201.7M. Industry reports show reduced flock, lower hatch numbers, and stable demand. Retail volume rose 4% YoY, with prices down 27%.

Cal-Maine Foods (CALM) reported a first-quarter net loss of $58.62M, down from a profit a year ago, with sales at $539.61M. The stock has declined 10.67% over 30 days and 21.94% over 90 days, but remains up 64.84% and 149.34% over three and five years. The company is expanding specialty egg and prepared foods offerings, aiming for higher margins. Analysts estimate a fair value of $68.33, with the stock currently trading at $66.67. Risks include avian influenza and oversupply pressures.

Cal-Maine Foods (CALM), the largest US egg producer, reported a weak Q1 FY2027 with net sales down 41.5% to $539.6M and a net loss of $58.6M. Specialty eggs and prepared foods, now 54.1% of sales, remained profitable. Retail demand for specialty eggs and exports rose, while supply may be tightening. Management is expanding prepared foods capacity. Conventional eggs, still dominant, saw a 59.5% sales drop due to price declines.

Cal-Maine Foods reported Q1 2027 sales of $539.61M and a net loss of $58.62M, both down year-over-year. Lower demand and pricing for conventional shell eggs impacted profitability, leading to a suspended dividend. The company continued share repurchases and rolled out Amino to improve data flows, focusing on operational efficiency. Investors now assess the impact of these results on the company's investment narrative, with a P/E of 53x and execution risks highlighted.

CAL-MAINE FOODS INC (CALM) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. The Company’s Annual Meeting of Stockholders was held on October 2, 202 6 (the “Annual Meeting”). Proposal No. 1: Election of Class II Directors. The following persons were nominated and elected to serve as members o

Cal-Maine Foods Inc. reported a 42% drop in net sales for its fiscal first quarter, with prices falling due to oversupply. The company posted a $59 million net loss. Shares fell 7.4%. According to the US Bureau of Labor Statistics, large grade A shell eggs averaged $2.272 a dozen in August. The company will not pay a cash dividend. U.S. egg output and laying flock increased year-over-year in August, but egg chicks placed for future hatchery supplies dropped 7%.

Stephens reduced its price target for Cal-Maine Foods (NASDAQ:CALM) to $70 from $80, citing weaker-than-expected Q1 2027 earnings of -$1.23 per share, driven by lower margins and higher expenses. The company's revenue was $539.6M, missing estimates. Management noted signs of industry supply rationalization but warned of ongoing challenges. The stock has fallen 24.63% over the past year.

Cal-Maine Foods shares fell 3.87% after reporting a wider Q1 loss and revenue decline due to lower egg prices. FingerMotion shares rose 30% following a $2.3M acquisition deal. Jabil shares dropped 6.68% despite beating earnings estimates and raising its outlook. Conagra Brands shares fell 2.48% despite an earnings beat due to declining sales volumes. FactSet shares rose 2.45% on strong Q4 results driven by AI growth. Yiren Digital shares fell 5% despite a narrower Q2 loss and revenue decline.

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.